35,000
Participants
Start Date
September 30, 2013
Primary Completion Date
December 31, 2015
Study Completion Date
June 30, 2016
Attenuated HAV Vaccine, H2 Strain
6.50 lgCCID50/Vial in babies aged 18-35 months\\6.50 lgCCID50/Vial in children aged 3-15 years \\6.50 lgCCID50/Vial in adults aged 16 up to 65 years old, only one dose (1Vial/dose).
Attenuated HAV Vaccine, L-A-1 Strain
6.50 lgCCID50/Vial in babies aged 18-35 months\\6.50 lgCCID50/Vial in children aged 3-15 years \\6.50 lgCCID50/Vial in adults aged 16 up to 65 years old, only one dose (1Vial/dose).
Inactivated HAV Vaccine, Lu8 Strain
320EU/Vial in babies aged 18-35 months\\320EU/Vial in children aged 3-15 years \\640EU/Vial in adults aged 16 up to 65 years old\\boost at month 6\\two-dose
Inactivated HAV Vaccine, TZ84 Strain
250U/Vial in babies aged 18-35 months\\250U/Vial in children aged 3-15 years \\500U/Vial in adults aged 16 up to 65 years old\\boost at month 6\\two-dose.
Institute of Medical Biology -Chinese Academy of Medical Sciences, Kunming
Jiangsu Province Centers for Disease Control and Prevention
NETWORK
Institute of Medical Biology, Chinese Academy of Medical Sciences
OTHER